|
... function," stated Brian J.G. Pereira, MD, President and CEO of AMAG Pharmaceuticals, Inc. "We plan to initiate a Phase II study of ferumoxytol for VE-MRI for the detection of clinically significant arterial stenosis or occlusion in subjects with ...
|
|
... announces that it has received approval from Israel's Ministry of Health (MOH) to commence its landmark Phase I/II safety and efficacy trial of its EPODURE Biopump for providing sustained treatment of anaemia in patients with chronic kidney disease. ...
|